01 1DARMERICA, LLC
02 1Hangzhou XinHan Biopharma Co., Ltd.
03 1Qingdao Biopeptek Co., Ltd.
04 2Zhejiang Peptites Biotech
01 3CJC-1295
02 2CJC-1295 Acetate
01 2China
02 2U.S.A
03 1Blank
NDC Package Code : 73212-003
Start Marketing Date : 2020-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71052-626
Start Marketing Date : 2019-06-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73569-052
Start Marketing Date : 2024-08-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 73569-060
Start Marketing Date : 2024-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84789-105
Start Marketing Date : 2024-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A CJC-1295 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CJC-1295, including repackagers and relabelers. The FDA regulates CJC-1295 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CJC-1295 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CJC-1295 supplier is an individual or a company that provides CJC-1295 active pharmaceutical ingredient (API) or CJC-1295 finished formulations upon request. The CJC-1295 suppliers may include CJC-1295 API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CJC-1295 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CJC-1295 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CJC-1295 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CJC-1295 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CJC-1295 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CJC-1295 suppliers with NDC on PharmaCompass.
We have 3 companies offering CJC-1295
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
